Nrf2 activators provide neuroprotection against 6-hydroxydopamine toxicity in rat organotypic nigrostriatal cocultures.

Journal of Neuroscience Research
Aubrey SiebertM Samir Jafri

Abstract

Oxidative stress and inflammation appear to play a critical role in the progression of Parkinson's disease. As a result, there has been growing interest in antioxidant pathways and how these pathways might be exploited to slow the progressive loss of dopamine neurons. One such pathway that has garnered attention recently is mediated by the transcription factor Nrf2 and is integral in orchestrating cells' antiinflammatory defense. Nrf2 controls the inducible expression of numerous antioxidant and phase 2 detoxification genes, such as glutathione S-transferase, heme oxygenase-1, and NAD(P)H:quinone oxidoreductase 1 (NQO1). Once activated, these genes work synergistically to maintain intracellular redox homeostasis. In this study, we test the hypothesis that Nrf2 activation can protect dopaminergic neurons against 6-hydroxydopamine (6-OHDA)-induced toxicity. Treatment of organotypic nigrostriatal cocultures with either tert-butylhydroquinone (tBHQ) or sulforaphane, known activators of Nrf2, mitigated dopaminergic cell loss. The observed protection appeared to be mediated, at least in part, by an increase in antioxidant activity. Simultaneous treatment of cultures with tBHQ and 6-OHDA increased NQO1 expression 17-fold compared with...Continue Reading

References

Mar 1, 1990·Journal of Neurochemistry·A H SchapiraC D Marsden
Feb 1, 1989·Journal of Neurochemistry·D T DexterC D Marsden
Dec 1, 1981·Journal of Neuroscience Methods·B H Gähwiler
May 17, 1996·Neuroscience Letters·D Plenz, S T Kitai
Dec 1, 2000·Biochemical and Biophysical Research Communications·L M Zipper, R T Mulcahy
Apr 12, 2002·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Ranjita BetarbetJ Timothy Greenamyre
Mar 28, 2003·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·T OkuboI Kano
May 23, 2003·Journal of Neurology·U Wüllner, T Klockgether
Feb 7, 2004·Proceedings of the National Academy of Sciences of the United States of America·Moon-Il KangMasayuki Yamamoto
Dec 21, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Negar Gharavi, Ayman O S El-Kadi
Mar 26, 2005·Brain Research. Molecular Brain Research·Claudia M TestaJ Timothy Greenamyre
Apr 21, 2005·The Journal of Biological Chemistry·Andy Y ShihTimothy H Murphy
Jun 25, 2005·Toxicological Sciences : an Official Journal of the Society of Toxicology·Rebekah J JakelJeffrey A Johnson
Jun 30, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jong-Min LeeJeffrey A Johnson
Mar 8, 2006·Cancer Letters·Melinda C Myzak, Roderick H Dashwood
Sep 9, 2006·Neurotoxicology·Neal C BurtonTomás R Guilarte
Dec 6, 2006·Drug Metabolism Reviews·Donna D Zhang
Jan 6, 2007·Journal of Neuropathology and Experimental Neurology·Chenere P RamseyKelly L Jordan-Sciutto
Mar 6, 2007·Brain Research·Rebekah J JakelJeffrey A Johnson

❮ Previous
Next ❯

Citations

Nov 10, 2010·Journal of Bioenergetics and Biomembranes·Tiffany Greco, Gary Fiskum
May 24, 2011·Translational Stroke Research·Michelle Y ChengRobert M Sapolsky
Mar 1, 2012·Antioxidants & Redox Signaling·Aracely Garcia-GarciaRodrigo Franco
Sep 22, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Natalia VanduynRichard Nass
Mar 4, 2010·BMC Medical Genetics·Malin von OtterHenrik Zetterberg
Nov 16, 2013·Journal of Molecular Neuroscience : MN·Behrang AlaniHadi Digaleh
Jul 19, 2013·Oxidative Medicine and Cellular Longevity·Chan LeeJung-Hee Jang
Dec 20, 2011·Mutation Research·Carmela FimognariPatrizia Hrelia
Dec 7, 2010·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Carlos Enrique Guerrero-BeltránYolanda Irasema Chirino
Jul 4, 2009·Free Radical Biology & Medicine·Fei ZhaoDonna D Zhang
Sep 20, 2011·Fundamental & Clinical Pharmacology·Sergi MasAmalia Lafuente
Feb 16, 2010·Journal of Neuroscience Research·Noriyuki YamamotoAkinori Akaike
Apr 29, 2010·BMB Reports·Young Cheul ChungByung Kwan Jin
Aug 29, 2013·Oxidative Medicine and Cellular Longevity·Andrea TarozziPatrizia Hrelia
Feb 24, 2015·Journal of Molecular Neuroscience : MN·Hyo Jin SonOnyou Hwang
Nov 24, 2011·Biochimica Et Biophysica Acta·Vittorio CalabreseEdward J Calabrese
Jan 1, 2014·Experimental Neurology·Juan Carlos CoronaMichael R Duchen
Jul 11, 2014·Neurochemical Research·Juan Carlos Corona, Michael R Duchen
Nov 9, 2014·Journal of Cell Communication and Signaling·V CalabreseA R Genazzani
Dec 29, 2016·Proceedings of the National Academy of Sciences of the United States of America·Gaia SkibinskiSteven Finkbeiner
Nov 12, 2015·PloS One·Hitoshi MurataMasakiyo Sakaguchi
Nov 15, 2016·Nutritional Neuroscience·Shinki MurakamiMasato Asanuma
Nov 10, 2010·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Natalie A KelseyDaniel A Linseman
Jun 29, 2010·Annals of Neurology·Wei-Bin ShenPaul J Yarowsky
Jul 25, 2019·Brain Circulation·Eric A Klomparens, Yuchuan Ding
May 28, 2011·Free Radical Research·Nilanjan GhoshSubhash C Mandal
Sep 18, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Kazuki TeradaYoshiharu Karube
Nov 20, 2020·International Journal of Molecular Sciences·Giovanni SchepiciEmanuela Mazzon
Dec 1, 2019·The Science of the Total Environment·Md Sahab UddinLotfi Aleya

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.